Meticulous Research®—a leading global market research
company, published a research report titled, ‘Spatial Genomics Market by Type
(Genomics, Transcriptomics) Technology (Sequencing, Imaging) Application
(Oncology, Neurology) Offering (Consumables, Instrument, Software) End User
(Pharmaceutical & Biotechnology, CRO) - Global Forecast to 2031.’
Download Free Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5763?utm_source=pr&utm_medium=social&utm_campaign=product&utm_content=06-02-2024
According to this latest publication from Meticulous
Research®, the global spatial genomics & transcriptomics market is
projected to reach $3.23 billion by 2031 at a CAGR of 27.8% from 2024 to 2031
The growth of the spatial genomics & transcriptomics market is driven by
the increasing applications of spatial genomics in drug discovery &
development, the growing use of spatial genomics in cancer research,
advancements in Next-generation Sequencing (NGS), the increasing use of spatial
genomics in biomarker detection, and the rising prevalence of cancer. However,
the lack of standardized approaches in genomics and concerns over the security
& privacy of genomic data restrain the growth of this market.
Furthermore, the rising adoption of personalized medicines
and gene therapies and increasing investments in spatial genomics are expected
to generate growth opportunities for the players operating in this market.
However, complexities in data analysis and slow technology adoption are major
challenges impacting market growth.
Key Players
The key players operating in the global spatial genomics
& transcriptomics market are NanoString Technologies, Inc. (U.S.), 10X
Genomics, Inc. (U.S.), Illumina, Inc. (U.S.), Oxford Nanopore Technologies Plc.
(U.K.), Akoya Biosciences, Inc. (U.S.), Revvity, Inc. (U.S.), S2 Genomics, Inc.
(U.S.), Cantata Bio (U.S.), Vizgen Inc. (U.S.), Biospyder Technologies Inc.
(U.S.), and Resolve Biosciences GmbH (Germany).
TOP 10 COMPANIES IN SPATIAL GENOMICS MARKET @ https://meticulousblog.org/top-10-companies-in-spatial-genomics-market/?utm_source=pr&utm_medium=social&utm_campaign=product&utm_content=06-02-2024
Spatial Genomics & Transcriptomics Market: Future
Outlook
The global spatial genomics market is segmented by Offering
(Instruments, Consumables, and Software & Services), Type (Genomics and
Transcriptomics), Technology (Imaging Based and Sequencing Based), Application
(Oncology, Neurology, and Other Applications), End User (Pharmaceutical &
Biotechnology Companies, Contract Research Organizations, and Other End Users),
and Geography. The study also evaluates industry competitors and analyzes their
market share at global and regional levels.
Among all offerings studied in this report, the instruments
segment is expected to grow at the highest CAGR during the forecast period. The
growing market is fueled by rising demand for instruments capable of detecting
transcriptional activity, user-friendly designs, and the presence of integrated
software in some devices. Key industry players are responding to researchers'
needs by introducing advanced instruments. For example, in June 2022, Resolve
Biosciences (Germany) unveiled the Molecular Cartography platform. This
multi-analyte, highly multiplexed spatial solution can visualize hundreds of
genes with subcellular resolution in a single run. Leveraging high-quality
optics for superior resolution, the platform enables the simultaneous
assessment of hundreds of genes.
Browse in depth @ https://www.meticulousresearch.com/product/spatial-genomics-market-5763?utm_source=pr&utm_medium=social&utm_campaign=product&utm_content=06-02-2024
Among all types studied in this report, in 2024, the
transcriptomics segment is expected to account for the largest share of the
spatial genomics & transcriptomics market. The increasing need to
understand the relationship between gene expression and its relative locations
within tissue to study disease pathology and understand normal cell development
is driving the demand for spatial transcriptomics.
Among all technologies studied in this report, the
sequencing based segment is expected to grow at the highest CAGR during the
forecast period. NGS platforms offer superior sequencing capacity at
substantially reduced costs, owing to which the use of NGS has increased in
genomic studies to produce massive genomic sequencing data. Additionally,
NGS-based spatial transcriptomics approaches ensure higher throughput compared
to imaging-based methodologies as the entire transcript information is detected
and massively parallel-processed, driving the market.
Speck to our analyst https://www.meticulousresearch.com/speak-to-analyst/cp_id=5763?utm_source=pr&utm_medium=social&utm_campaign=product&utm_content=06-02-2024
Among all applications studied in this report, the oncology
segment is expected to grow at the highest CAGR during the forecast period. The
growth of this segment is attributed to the increasing use of spatial genomics
for oncology biomarker detection, increasing demand for spatial genomics
products for oncology research applications, such as anti-cancer drug studies,
drug discoveries, and personalized medicine, and the rising prevalence of
cancer.
Among all end users studied in this report, in 2024, the
pharmaceutical and biotechnology companies segment is expected to account for
the largest share of the spatial genomics & transcriptomics market. The
growth of the segment is attributed to pharmaceutical & biotechnology
companies allocating significant resources to their research activities.
Spatial genomics has become increasingly important in maintaining precision and
accuracy in drug research and development and gaining a detailed view of cell
structure.
Request Free Research Report Sample @ https://www.meticulousresearch.com/request-sample-report/cp_id=5763?utm_source=pr&utm_medium=social&utm_campaign=product&utm_content=06-02-2024
This research report analyzes major geographies and provides
a comprehensive analysis of North America (U.S. and Canada), Europe (Germany,
France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (China,
Japan, India, and the Rest of Asia-Pacific), Latin America, and the Middle East
& Africa.
Among all regions studied in this report, Asia-Pacific is
expected to grow at the highest CAGR during the forecast period. The highest
CAGR of the region is attributed to the rising research funding in the
healthcare and pharmaceutical industry, the rising number of research
laboratories, the advancing research framework, and the growing number of
research laboratories in countries such as China, India, Japan, South Korea,
and others.
Download Free Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5763?utm_source=pr&utm_medium=social&utm_campaign=product&utm_content=06-02-2024
